Growth and Development Symposium: Development, characterization, and use of a porcine epiblast-derived liver stem cell line: ARS-PICM-19

Journal of Animal Science

Volumn 91, Issue 1, 2013, Pages 66-77

  Talbot, N C ^a   Caperna, T J ^a   Garrett, W M ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Bile duct; Cell line; Differentiation; Hepatocyte; Liver; Stem cell

Indexed keywords

ANIMAL; ARTICLE; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; GERM LAYER; LIVER; LIVER CELL; PHYSIOLOGY; PRENATAL DEVELOPMENT; STEM CELL; SWINE; TOTIPOTENT STEM CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; GERM LAYERS; HEPATOCYTES; LIVER; STEM CELLS; SWINE; TOTIPOTENT STEM CELLS;

EID: 84882578787     PISSN: 00218812     EISSN: 15253163     Source Type: Journal    
DOI: 10.2527/jas.2012-5748     Document Type: Article

References (71)

1. Bertz, R. J., and G. R. Granneman. 1997. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet. 32:210-258.
2. Block, G. D., J. Locker, W. C. Bowen, B. E. Petersen, S. Katyal, S. C. Strom, T. Riley, T. A. Howard, and G. K. Michalopoulos. 1996. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J. Cell. Biol. 132:1133-1149.
3. Brill, S., P. Holst, S. Sigal, I. Zvibel, A. Fiorino, A. Ochs, U. Somasundaran, and L. M. Reid. 1993. Hepatic progenitor popu-lations in embryonic, neonatal, and adult liver. Proc. Soc. Exp. Biol. Med. 204:261-269.
4. Brook, F. A., and R. L. Gardner. 1997. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA. 94:5709-5712.
5. Caperna, T. J., L. A. Blomberg, W. M. Garrett, and N. C. Talbot. 2011. Culture of porcine hepatocytes or bile duct epithelial cells by inductive serum free media. In Vitro Cell. Dev. Biol. Anim. 47:218-233.
6. Caperna, T. J., A. E. Shannon, L. A. Blomberg, W. M. Garrett, and T. G. Ramsay. 2010. Identification of protein carbonyls in serum of the fetal and neonatal pig. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 156:189-196.
7. Cardinale, V., Y. Wang, G. Carpino, C. B. Cui, M. Gatto, M. Rossi, P. B. Berloco, A. Cantafora, E. Wauthier, M. E. Furth, L. Inverardi, J. Dominguez-Bendala, C. Ricordi, D. Gerber, E. Gaudio, D. Alvaro, and L. Reid. 2011. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 54:2159-2172.
8. Cardinale, V., Y. Wang, G. Carpino, L. M. Reid, E. Gaudio, and D. Alvaro. 2012. Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands. Hepatology 55:2041-2042.
9. Carpentier, B., A. Gautier, and C. Legallais. 2009. Artificial and bioartificial liver devices: Present and future. Gut 58:1690-1702.
10. Chamuleau, R. A., T. Deurholt, and R. Hoekstra. 2005. Which are the right cells to be used in a bioartificial liver? Metab. Brain Dis. 20:327-335.
11. Demetriou, A. A., R. S. Brown, R. W. Busuttil, J. Fair, B. M. McGuire, P. Rosenthal, J. S. Am Esch, 2nd, J. Lerut, S. L. Nyberg, M. Salizzoni, E. A. Fagan, B. de Hemptinne, C. E. Broelsch, M. Muraca, J. M. Salmeron, J. M. Rabkin, H. J. Metselaar, D. Pratt, M. De La Mata, L. P. McChesney, G. T. Everson, P. T. Lavin, A. C. Stevens, Z. Pitkin, and B. A. Solomon. 2004. Prospective, randomized, multicenter, controlled trial of bioartificial liver in treating acute liver failure. Ann. Surg. 239:660-670.
12. Di Nicuolo, G., M. P. van de Kerkhove, R. Hoekstra, M. G. Beld, P. Amoroso, S. Battisti, M. Starace, E. di Florio, V. Scuderi, S. Scala, A. Bracco, A. Mancini, R. A. Chamuleau, and R. Calise. 2005. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver. Xenotransplantation 12:286-292.
13. Diaz, G. J., and E. J. Squires. 2003. Phase II in vitro metabolism of 3-methylindole metabolites in porcine liver. Xenobiotica 33:485-498.
14. Donato, M. T., J. V. Castell, and M. J. Gómez-Lechón. 1999. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: Comparison with other hepatic cellular models. J. Hepatol. 31:542-549.
15. Dunn, J. C., M. L. Yarmush, H. G. Koebe, and R. G. Tompkins. 1989. Hepatocyte function and extracellular matrix geometry: Longterm culture in a sandwich configuration. FASEB J. 3:174-177.
16. Enzan, H., T. Ohkita, H. Fujuta, and S. Iijima. 1974. Light and electron microscopic studies on the development of periportal bile ducts of the human embryo. Acta. Pathol. Jpn. 24:427-447.
17. Evans, M. J., and M. H. Kaufman. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
18. Filippi, C., S. A. Keatch, D. Rangar, L. J. Nelson, P. C. Hayes, and J. N. Plevris. 2004. Improvement of C3A cell metabolism for usage in bioartificial liver support systems. J. Hepatol. 41:599-605.
19. Gómez-Lechón, M. J., M. T. Donato, J. V. Castell, and R. Jover. 2004. Human hepatocytes in primary culture: The choice to investigate drug metabolism in man. Curr. Drug Metab. 5:443-462.
20. Guillouzo, A. 1998. Liver cell models in in vitro toxicology. Environ. Health Perspect. 106 (Suppl2):511-532.
21. Han, D. W., N. Tapia, A. Hermann, K. Hemmer, S. Höing, M. J. Araúzo-Bravo, H. Zaehres, G. Wu, S. Frank, S. Moritz, B. Greber, J. H. Yang, H. T. Lee, J. C. Schwamborn, A. Storch, and H. R. Schöler. 2012. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 10:465-472.
22. Herrmann, U., G. Dockter, and F. Lammert. 2010. Cystic fibrosis associated liver disease. Best Pract. Res. Clin. Gastroenterol. 24:585-592.
23. Hoekstra, R., and R. A. Chamuleau. 2002. Recent developments on human cell lines for the bioartificial liver. Int. J. Artif. Organs 25:182-191.
24. Ishii, M., B. Vroman, and N. F. LaRusso. 1989. Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology 97:1236-1247.
25. Kia, R., R. L. Sison, J. Heslop, N. R. Kitteringham, N. Hanley, J. S. Mills, B. K. Park, and C. E. Goldring. 2012. Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: Are we there yet? Br. J. Clin. Pharmacol.
26. Kobayashi, N., T. Okitsu, and N. Tanaka. 2003. Cell choice for bioartificial livers. Keio J. Med. 52:151-157. doi:10.2302/kjm.52.151
27. Martin, G. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78:7634-7638.
28. Nebbia, C., L. Ceppa, M. Dacasto, C. Nachtmann, and M. Carletti. 2001. Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. J. Vet. Pharmacol. Ther. 24:399-403.
29. Nishikawa, Y., Y. Doi, H. Watanabe, T. Tokairin, Y. Omori, M. Su, T. Yoshioka, and K. Enomoto. 2005. Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. Am. J. Pathol. 166:1077-1088.
30. Nyberg, S. L., R. P. Remmel, H. J. Mann, M. V. Peshwa, W. S. Hu, and F. B. Cerra. 1994. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann. Surg. 220:59-67.
31. Oze, H., M. Hirao, K. Ebina, K. Shi, Y. Kawato, S. Kaneshiro, H. Yoshikawa, and J. Hashimoto. 2012. Impact of medium volume and oxygen concentration in the incubator on pericellular oxygen concentration and differentiation of murine chondrogenic cell culture. In Vitro Cell. Dev. Biol. Anim. 48:123-130.
32. Parent, R., M. J. Marion, L. Furio, C. Trépo, and M. A. Petit. 2004. Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126:1147-1156.
33. Pettersen, E. O., L. H. Larsen, N. B. Ramsing, and P. Ebbesen. 2005. Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors. Cell Prolif. 38:257-267.
34. Przybyla, L. M., and J. Voldman. 2012. Attenuation of extrinsic signaling reveals the importance of matrix remodeling on maintenance of embryonic stem cell self-renewal. Proc. Natl. Acad. Sci. USA 109:835-840.
35. Reddy, J. K., and M. S. Rao. 2006. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G852-G858.
36. Rogée, S., N. Talbot, T. Caperna, J. Bouquet, E. Barnaud, and N. Pavio. 2012. New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J Gen Virol. Nov 21. [Epub ahead of print]
37. Rodríguez-Antona, C., M. T. Donato, A. Boobis, R. J. Edwards, P. S. Watts, J. Vicente Castell, and J. Gómez-Lechón. 2002. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32:505-520.
38. Shah, K. D., and M. A. Gerber. 1989. Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies. Arch. Pathol. Lab. Med. 113:1135-1138.
39. Shimada, T., H. Yamazaki, M. Mimura, Y. Inui, and F. P. Guengerich. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:414-423.
40. Strain, A. J., and J. M. Neuberger. 2002. A bioartificial liver-State of the art. Science 295:1005-1009.
41. Strick-Marchand, H., and M. C. Weiss. 2003. Embryonic liver cells and permanent lines as models for hepatocyte and bile duct cell differentiation. Mech. Dev. 120:89-98.
42. Stoll, B., D. A. Horst, L. Cui, X. Chang, K. J. Ellis, D. L. Hadsell, A. Suryawan, A. Kurundkar, A. Maheshwari, T. A. Davis, and D. G. Burrin. 2010. Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs. J. Nutr. 140:2193-2200.
43. Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
44. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
45. Talbot, N. C., L. A. Blomberg, W. M. Garrett, and T. J. Caperna. 2010a. Feeder-independent continuous culture of the PICM-19 pig liver stem cell line. In Vitro Cell. Dev. Biol. Anim. 46:746-757.
46. Talbot, N. C., and T. J. Caperna. 1998. Selective and organotypic culture of intrahepatic bile duct cells from adult pig liver. In Vitro Cell. Dev. Biol. Anim. 34:785-798.
47. Talbot, N. C., and T. J. Caperna. 2013. A feeder-cell independent subpopulation of the PICM-19 pig liver stem cell line capable of long-term growth and extensive expansion. Cytotechnology. In press.
48. Talbot N. C., T. J. Caperna, L. Blomberg, P. G. Graninger, and L. S. Stodieck. 2010b. The effects of space flight and microgravity on the growth and differentiation of PICM-19 pig liver stem cells. In Vitro Cell. Dev. Biol. Anim. 46:502-515.
49. Talbot, N. C., T. J. Caperna, J. L. Edwards, W. Garrett, K. D. Wells, and A. D. Ealy. 2000. Bovine blastocyst-derived trophectoderm and endoderm cell cultures: Interferon-tau and transferrin expression as respective in vitro markers. Biol. Reprod. 62:235-247.
50. Talbot, N. C., T. J. Caperna, L. T. Lebow, D. Moscioni, V. G. Pursel, and C. E. Rexroad, Jr. 1996a. Ultrastructure, enzymatic, and transport properties of the PICM-19 bipotent liver cell line. Exp. Cell Res. 225:22-34.
51. Talbot, N. C., T. J. Caperna, and K. D. Wells. 2002. The PICM-19 cell line as an in vitro model of liver bile ductules: Effects of cAMP inducers, biopeptides and pH. Cells Tissues Organs 171:99-116.
52. Talbot, N. C., T. J. Caperna, R. R. Willard, J. H. Meekin, and W. M. Garrett. 2010c. Characterization of two subpopulations of the PICM-19 porcine liver stem cell line for use in cell-based extra corporeal liver assistance devices. Int. J. Artif. Organs 33:348-361.
53. Talbot, N. C., C. W. Kemp, T. J. Caperna, C. E. Rexroad, Jr., V. G. Pursel, and A. M. Powell. 1999. Artificial liver device. U.S. Patent 5,866,420. Date issued: Feb 2.
54. Talbot, N. C., and M. J. Paape. 1996. Continuous culture of pig tissue derived macrophages. Meth. Cell Sci. 18:315-327.
55. Talbot, N. C., V. G. Pursel, C. E. Rexroad Jr., T. J. Caperna, A. M. Powell, and R. T. Stone. 1994a. Colony isolation and secondary culture of fetal porcine hepatocytes on STO feeder cells. In Vitro Cell. Dev. Biol. Anim. 30:851-858.
56. Talbot, N. C., C. E. Rexroad, Jr., A. Powell, V. G. Pursel, T. J. Caperna, S. L. Ogg, and N. D. Nel. 1994b. A continuous culture of pluripotent fetal hepatocytes derived from the 8-day epiblast of the pig. In Vitro Cell. Dev. Biol. Anim. 30:843-850.
57. Talbot, N. C., C. E. Rexroad, Jr., V. G. Pursel, and A. M. Powell. 1996b. Hepatocyte cell line derived from the epiblast of pig blastocysts. U.S. Patent 5,532,156. Date issued: Jul 2.
58. Talbot, N. C., C. E. Rexroad, Jr., V. G. Pursel, A. M. Powell, and N. D. Nel. 1993. Culturing the epiblast cells of the pig blastocyst. In Vitro Cell. Dev. Biol. Anim. 29:543-554.
59. Tanaka, M. 1974. A histochemical study on the activity of gamma-glutamyl transpeptidase in liver disease. Acta. Path. Jpn. 24:651-665.
60. Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall, and J. M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
61. Thomson, J. A., J. Kalishman, T. G. Golos, M. Durning, C. P. Harris, R. A. Becker, and J. P. Hearn. 1995. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92:7844-7848.
62. Turner, R., O. Lozoya, Y. Wang, V. Cardinale, E. Gaudio, G. Alpini, G. Mendel, E. Wauthier, C. Barbier, D. Alvaro, and L. M. Reid. 2011. Human hepatic stem cell and maturational liver lineage biology. Hepatology 53:1035-1045.
63. Ulrichova, J., Z. Dvorak, J. Vicar, J. Lata, J. Smrzova, A. Sedo, and V. Simanek. 2001. Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthri dine alkaloids. Toxicol. Lett. 125:125-132.
64. Van Eyken, P., R. Sciot, and V. Desmet. 1988. Intrahepatic bile duct development in the rat: A cytokeratin-immunohistochemical study. Lab. Invest. 59:52-59.
65. Vermeir, M., P. Annaert, R. N. Mamidi, D. Roymans, W. Meuldermans, and G. Mannens. 2005. Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opin. Drug Metab. Toxicol. 1:75-90.
66. Wang, L., J. Sun, L. Li, D. Mears, M. Horvat, and A. G. Sheil. 1998. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant. 7:459-468.
67. Wilkening, S., F. Stahl, and A. Bader. 2003. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab. Dispos. 31:1035-1042.
68. Willard, R. R., J. H. Meekin, G. W. Peters, M. J. Baun, J. C. Gerlach, N. C. Talbot, and T. J. Caperna. 2008. Maintenance of hepatic cell function by the PICM-19H porcine liver stem cell line cultured in a bioartificial liver. In: 6th Annual Meeting of the International Society for Stem Cell Research, Philadelphia, PA. p. 125.
69. Willard, R. R., N. W. Shappell, J. H. Meekin, N. C. Talbot, and T. J. Caperna. 2010. Cytochrome P450 expression profile of the PICM-19H pig liver cell line: potential application to rapid liver toxicity assays. In Vitro Cell. Dev. Biol. Anim. 46:11-19.
70. Wilson, W. J., C. S. Groat, and E. H. Leduc. 1963. Histogenesis of the liver. Ann. N.Y. Acad. Sci. 111:8-22.
71. Yan, Z., and G. W. Caldwell. 2001. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr. Top. Med. Chem. 1:403-425.